European Lung Cancer Congress 2025
| Datum: | 26. März – 29. März 2025 |
| Zeiten: |
▪ Mi. 11:00 – 18:15 ▪ Do. 08:15 – 17:00 ▪ Fr. 08:15 – 16:15 ▪ Sa. 08:15 – 13:00 |
| Location: | Paris Expo Porte de Versailles Pavilion 7 |
| Ort: | 2 Pl. de la Prte de Versailles, 92170 Paris, International |
| Kontakt: |
Organisation Contacts: Alessia Mora and Chiara Sommaruga Tel: +41 (0)91 973 19 62 E-mail: elcc@esmo.org Scientific Programme and Abstracts Contacts: Federica Frigerio and Serena Zagni Tel: +41 91 97 31 938 and +41 91 97 31 961 E-mail: programme@esmo.org |
The European Lung Cancer Congress 2025 will provide insights into the prevention, diagnosis and biology-informed, multi-disciplinary management of thoracic malignancies. Specifically, the Congress will include educational and scientific sessions covering:
- Prevention, screening and early diagnosis of thoracic tumours;
- Recent developments in molecular characterization of lung cancer;
- New breakthroughs from immunologic and targeted therapies;
- The evolving role of multidisciplinary decision-making in lung cancer;
- State of the art for NSCLC, SCLC, mesothelioma and mediastinal tumours
Learning objectives
- Learn about novel biomarker-guided treatment modalities for patients with lung cancer.
- Be update on the optimal use of immunotherapy to treat patients with lung cancer.
- Learn how to best sequence or combine multimodal therapies in common and rare thoracic tumours
- Update on novel and targeted therapies to treat patients with lung cancer.
- Review the emerging contribution of precision medicine, liquid biopsies, omics and AI technologies for the optimal management of thoracic tumors.